117 related articles for article (PubMed ID: 20044604)
1. A new amino acid derivative of ursodeoxycholate, (N-L-Glutamyl)-UDCA (UDCA-Glu), to selectively release UDCA in the colon.
Asciutti S; Castellani D; Nardi E; Morelli O; Clementi M; Chistolini F; Gentili G; Setchell KD; O'Connell N; Pellicciari R; Clerici C
Anticancer Res; 2009 Dec; 29(12):4971-9. PubMed ID: 20044604
[TBL] [Abstract][Full Text] [Related]
2. Enrichment of the more hydrophilic bile acid ursodeoxycholic acid in the fecal water-soluble fraction after feeding to rats with colon polyps.
Batta AK; Salen G; Holubec H; Brasitus TA; Alberts D; Earnest DL
Cancer Res; 1998 Apr; 58(8):1684-7. PubMed ID: 9563483
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory effects of ursodeoxycholic acid on N-methylnitrosourea-induced colon carcinogenesis and colonic mucosal telomerase activity in F344 rats.
Narisawa T; Fukaura Y; Terada K; Sekiguchi H
J Exp Clin Cancer Res; 1999 Jun; 18(2):259-66. PubMed ID: 10464717
[TBL] [Abstract][Full Text] [Related]
4. Effect of ursodeoxycholic acid on azoxymethane-induced aberrant crypt foci formation in rat colon: in vitro potential role of intracellular Ca2+.
Momen MA; Monden Y; Houchi H; Umemoto A
J Med Invest; 2002 Feb; 49(1-2):67-73. PubMed ID: 11901763
[TBL] [Abstract][Full Text] [Related]
5. Kinetic analysis of bile acids in the feces of colorectal cancer patients by gas chromatography-mass spectrometry (GC-MS).
Tadano T; Kanoh M; Kondoh H; Matsumoto M; Mimura K; Kanoh Y; Sakamoto K; Kamano T
Rinsho Byori; 2007 May; 55(5):417-27. PubMed ID: 17593686
[TBL] [Abstract][Full Text] [Related]
6. Effects of bile acids on 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced aberrant crypt foci and DNA adduct formation in the rat colon.
Ueyama Y; Monden Y; He XB; Lin CX; Momen MA; Mimura S; Umemoto A
J Exp Clin Cancer Res; 2002 Dec; 21(4):577-83. PubMed ID: 12636105
[TBL] [Abstract][Full Text] [Related]
7. Effective treatment of unconjugated hyperbilirubinemia with oral bile salts in Gunn rats.
Cuperus FJ; Hafkamp AM; Havinga R; Vitek L; Zelenka J; Tiribelli C; Ostrow JD; Verkade HJ
Gastroenterology; 2009 Feb; 136(2):673-82.e1. PubMed ID: 19027011
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholic acid inhibits the initiation and postinitiation phases of azoxymethane-induced colonic tumor development.
Wali RK; Stoiber D; Nguyen L; Hart J; Sitrin MD; Brasitus T; Bissonnette M
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1316-21. PubMed ID: 12433708
[TBL] [Abstract][Full Text] [Related]
9. Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis.
Invernizzi P; Setchell KD; Crosignani A; Battezzati PM; Larghi A; O'Connell NC; Podda M
Hepatology; 1999 Feb; 29(2):320-7. PubMed ID: 9918905
[TBL] [Abstract][Full Text] [Related]
10. Results of a phase I multiple-dose clinical study of ursodeoxycholic Acid.
Hess LM; Krutzsch MF; Guillen J; Chow HH; Einspahr J; Batta AK; Salen G; Reid ME; Earnest DL; Alberts DS
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):861-7. PubMed ID: 15159320
[TBL] [Abstract][Full Text] [Related]
11. Studies of serum and feces bile acids determination by gas chromatography-mass spectrometry.
Tadano T; Kanoh M; Matsumoto M; Sakamoto K; Kamano T
Rinsho Byori; 2006 Feb; 54(2):103-10. PubMed ID: 16548228
[TBL] [Abstract][Full Text] [Related]
12. Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon.
Ward JBJ; Lajczak NK; Kelly OB; O'Dwyer AM; Giddam AK; Ní Gabhann J; Franco P; Tambuwala MM; Jefferies CA; Keely S; Roda A; Keely SJ
Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G550-G558. PubMed ID: 28360029
[No Abstract] [Full Text] [Related]
13. delta 22-Ursodeoxycholic acid, a unique metabolite of administered ursodeoxycholic acid in rats, indicating partial beta-oxidation as a major pathway for bile acid metabolism.
Setchell KD; Yamashita H; Rodrigues CM; O'Connell NC; Kren BT; Steer CJ
Biochemistry; 1995 Apr; 34(13):4169-78. PubMed ID: 7703228
[TBL] [Abstract][Full Text] [Related]
14. Modulation of rat hepatocyte proliferation by bile salts: in vitro and in vivo studies.
Barone M; Francavilla A; Polimeno L; Ierardi E; Romanelli D; Berloco P; Di Leo A; Panella C
Hepatology; 1996 May; 23(5):1159-66. PubMed ID: 8621149
[TBL] [Abstract][Full Text] [Related]
15. Effect of amount and types of dietary fat on intestinal bacterial 7 alpha-dehydroxylase and phosphatidylinositol-specific phospholipase C and colonic mucosal diacylglycerol kinase and PKC activities during stages of colon tumor promotion.
Reddy BS; Simi B; Patel N; Aliaga C; Rao CV
Cancer Res; 1996 May; 56(10):2314-20. PubMed ID: 8625306
[TBL] [Abstract][Full Text] [Related]
16. A two-year prospective study of the effect of ursodeoxycholic acid on urinary bile acid excretion and liver morphology in cystic fibrosis-associated liver disease.
Lindblad A; Glaumann H; Strandvik B
Hepatology; 1998 Jan; 27(1):166-74. PubMed ID: 9425933
[TBL] [Abstract][Full Text] [Related]
17. Differing effect of chenodeoxycholic acid and ursodeoxycholic acid on bile acids in rat colonic wall and contents.
Kurtz WJ; Guldutuna S; Leuschner U
Tokai J Exp Clin Med; 1988 Jun; 13(2):91-7. PubMed ID: 3250006
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of ursodeoxycholic acid bioavailability from immediate- and sustained-release preparations using gas chromatography-mass spectrometry and high-performance liquid chromatography.
Scalia S; Scagliarini R; Pazzi P
Arzneimittelforschung; 2000 Feb; 50(2):129-34. PubMed ID: 10719615
[TBL] [Abstract][Full Text] [Related]
19. The site-specific delivery of ursodeoxycholic acid to the rat colon by sulfate conjugation.
Rodrigues CM; Kren BT; Steer CJ; Setchell KD
Gastroenterology; 1995 Dec; 109(6):1835-44. PubMed ID: 7498648
[TBL] [Abstract][Full Text] [Related]
20. Absorption of 7-ketolithocholic acid in rat jejunum, ileum and colon.
Walker S; Stiehl A; Raedsch R; Klöters P; Kommerell B
Z Gastroenterol; 1985 Dec; 23(12):681-3. PubMed ID: 4090568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
